In this study, loss of LPCAT3 increased membrane phospholipid saturation and induced stress-induced autophagy, while liver-specific overexpression of LPCAT3 showed potential in alleviating NASH-related inflammation and fibrosis (Tian et al., 2024). Here, LPCAT3 is linked to metabolic dysfunction-associated steatohepatitis.